Project Provider: NOVUS LIFE SCIENCES
Country/Region: Hong Kong
This project is a diagnostic and therapeutic technique for osteoarthritis, while an imaging diagnostic software based on big data can be developed to diagnose degenerative osteoarthritis at an early stage. This project focuses on the development of biomaterials for different surgical procedures to replace the previous bone material and cartilage substitutes. The company plans to apply for FDA, CE and CFDA registration in 2018, and the animal treatment program will be launched on the market in Q4 2017. The project received the following honors: Support from the Austrian government funding agency FFG in 2017; Winner of Jump starter (Healthy Ageing) of Alibaba Entrepreneurship Fund; One of the 15 Technology Startups in 2016 Global Innovation Forum and the Hong Kong Champion; Global Top 20 Most Popular Startups by CNBC in 2014.